Global pharma major Lupin Limited has received approval for its tavaborole topical solution, 5%, from the United States Food and Drug Administration (FDA), to market a generic equivalent of Kerydin topical solution, 5%, of Anacor Pharmaceuticals, Inc.The product will be manufactured at Lupin's facility in Pithampur, India.Tavaborole topical solution, 5%, is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes.Tavaborole topical solution had estimated annual sales of US$ 76 million in the US, according to IQVIA MAT December 2020.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!